FluoSphera Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.43M

  • Investors
  • 13

FluoSphera General Information

Description

Developer of a drug discovery platform designed to help companies and organizations protect people from harmful compounds. The company's platform helps discover more efficient drugs with fewer adverse side effects and reduces animal experimentation, enabling companies to address the complexity of human physiological responses and efficiently protect populations from hazardous chemicals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Care Of Fongit, Route de la Galaise 34
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Care Of Fongit, Route de la Galaise 34
  • Plan-les-Ouates
  • 1228 Geneva
  • Switzerland
+41 022

FluoSphera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FluoSphera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Seed Round 10-Dec-2025 $1.43M Completed Generating Revenue
10. Grant 01-Jan-2024 Completed Generating Revenue
9. Seed Round 01-Mar-2023 Completed Generating Revenue
8. Seed Round 09-Feb-2022 Completed Generating Revenue
7. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
6. Grant 02-Nov-2021 Completed Generating Revenue
5. Grant 08-Aug-2021 Completed Startup
4. Grant 30-Jun-2021 Completed Startup
3. Grant 01-Feb-2021 $475K Completed Startup
2. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view FluoSphera’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FluoSphera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a drug discovery platform designed to help companies and organizations protect people from harmful compound
Drug Discovery
Geneva, Switzerland
8 As of 2026

Geneva, Switzerland
 

Lausanne, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FluoSphera Competitors (2)

One of FluoSphera’s 2 competitors is Light Chain Bioscience, a Formerly PE-Backed company based in Geneva, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Light Chain Bioscience Formerly PE-Backed Geneva, Switzerland
AC Immune Formerly VC-backed Lausanne, Switzerland
You’re viewing 2 of 2 competitors. Get the full list »

FluoSphera Patents

FluoSphera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4767056-A1 Color- and position-based identification of multicellular structures for the multiplexed and individualized analysis of multi-tissue co-cultures Pending 22-Aug-2023
WO-2025040692-A1 Color- and position-based identification of multicellular structures for the multiplexed and individualized analysis of multi-tissue co-cultures Inactive 22-Aug-2023

FluoSphera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FluoSphera Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Olive Venture Partners Venture Capital Minority
Soulmates Ventures Accelerator/Incubator Minority
Innosuisse Government
EFI Lake Geneva Ventures Venture Capital Minority
Mountain Labs Accelerator/Incubator Minority
You’re viewing 5 of 13 investors. Get the full list »

FluoSphera FAQs

  • When was FluoSphera founded?

    FluoSphera was founded in 2021.

  • Where is FluoSphera headquartered?

    FluoSphera is headquartered in Geneva, Switzerland.

  • What is the size of FluoSphera?

    FluoSphera has 8 total employees.

  • What industry is FluoSphera in?

    FluoSphera’s primary industry is Drug Discovery.

  • Is FluoSphera a private or public company?

    FluoSphera is a Private company.

  • What is the current valuation of FluoSphera?

    The current valuation of FluoSphera is .

  • What is FluoSphera’s current revenue?

    The current revenue for FluoSphera is .

  • How much funding has FluoSphera raised over time?

    FluoSphera has raised $2.68M.

  • Who are FluoSphera’s investors?

    Olive Venture Partners, Soulmates Ventures, Innosuisse, EFI Lake Geneva Ventures, and Mountain Labs are 5 of 13 investors who have invested in FluoSphera.

  • Who are FluoSphera’s competitors?

    Light Chain Bioscience and AC Immune are competitors of FluoSphera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process